An easier time for restricted mobility in HCM patients?

Published Date: 13 Mar 2023

Electrophysiologist John Mandrola, MD. and Rachel Lampert, MD, reviewed the LIVE-HCM study comparing exercise and no exercise in people with hypertrophic cardiomyopathy.

Read Full News

Latest News

Why Order a CT for Patients With COPD

Imaging helps pinpoint etiotypes, identify COPD phenotypes, and inform treatment.

Paxlovid Still Tops Treatment List for High-Risk COVID Cases

Dr Lum discusses COVID-19 management in the outpatient setting, where Paxlovid is still the first-line treatment for high-risk adults.

The Special Antidepressant That Treats Long COVID

Endometriosis Hormonal Treatments Compromise Bone Health

Hormonal suppression for endometriosis results in a reduction in bone mineral density after up to a year of treatment, with each therapy showing distinct effects, according to a meta-analysis.

DBT Detects Early Cancers With Unchanged Interval Rates

Digital breast tomosynthesis combined with digital mammography detects more early-stage breast cancers, but the incidence shows no reduction in the interval before a follow-up round.

Alcohol Use Disorder Meds May Reduce Hospital Use and Costs

Medications for alcohol use disorder are associated with reduced alcohol-related healthcare utilization and cost savings in real-world settings.

Todays Updates

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though uptake remains slow and incomplete in the US.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.

Todays Updates

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though uptake remains slow and incomplete in the US.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.

Latest News

Imaging helps pinpoint etiotypes, identify COPD phenotypes, and inform treatment.

Dr Lum discusses COVID-19 management in the outpatient setting, where Paxlovid is still the first-line treatment for high-risk adults.

Hormonal suppression for endometriosis results in a reduction in bone mineral density after up to a year of treatment, with each therapy showing distinct effects, according to a meta-analysis.

Digital breast tomosynthesis combined with digital mammography detects more early-stage breast cancers, but the incidence shows no reduction in the interval before a follow-up round.

Medications for alcohol use disorder are associated with reduced alcohol-related healthcare utilization and cost savings in real-world settings.

News All Time

Adverse Childhood Experiences Linked to TRD in Adulthood

Exposure to adverse childhood experiences is linked to an increased risk for treatment-resistant depression in adulthood, even after accounting for known risk factors, new data show.

GPs Reject Contract as NHS Reports Record Access

GPs in England have opposed new contract terms in a BMA ballot as NHS England reports a surge in online consultation submissions.

Some Smokers Had Delayed LC Risk, When to Rescreen Debated

A population-based, prospective cohort study conducted in China finds that lung cancer risk remains low until 3 years after a negative low-dose CT screen.

Carboplatin De-Escalation Gains Ground in Early HER2+ BC

New data confirm similar response rates with fewer toxicities when carboplatin is dropped from standard neoadjuvant therapy in early HER2-positive breast cancer.

Anti-Müllerian Hormone and Ovarian Volume Predict PCOS

A model incorporating anti-Müllerian hormone, ovarian volume, hirsutism score, and maximum menstrual cycle length predicts polycystic ovary syndrome.

EMA Recommends Dropping Tecovirimat for Mpox

The decision was based on results of clinical trials suggesting its lack of effectiveness for mpox.

FDA Approves First Gene Therapy for Severe LAD-1

Marne-cel now offers an option to children with the rare immune disorder who lack a sibling donor for stem cell transplantation.

Kidney Risks From COVID Outpace Influenza Impact

COVID is linked to higher risks for subsequent acute kidney injury, chronic kidney disease, and end-stage renal disease than influenza, a new analysis shows.

Cost-Related Nonadherence More Common in Black Canadians

Fewer Black adults than White adults have insurance coverage for prescriptions, according to a new study.

Higher Meat Intake, Lower Dementia Risk — But Only in APOE4

Higher meat intake was linked to lower dementia risk in APOE4 carriers but no other groups, highlighting the potential for genotype-specific dietary guidance.

Hydration Intervention Fails to Prevent Kidney Stones

Although it increased urine volume, a behavioral hydration intervention did not significantly reduce kidney stone recurrence risk.

How to De-escalate Angry or Agitated Patients

De-escalating an angry or agitated patient can be difficult, but it’s important for everyone’s safety and good patient care.

Advanced CKD Symptoms: Women Start Ahead, Men Catch Up Fast

A European cohort of older patients shows that women with advanced CKD report more symptoms than men, but men experience a faster increase in symptom burden over time and as kidney function declines.

Do Isolated Tumor Cells Affect Low-Risk Endometrial Cancer?

A large observational analysis suggests that the presence of isolated tumor cells may signal worse survival in low-risk endometrial cancer.

Comorbid Arthritis and IBD: When Does Each Arise?

The incidence of inflammatory arthritis was highest in the 6 months preceding inflammatory bowel diagnoses for patients younger than 18 years.

Recommended News For You

Radiation therapy can promote amphiregulin, which increases growth of metastases

On all CAR-T products, the FDA is calling for a new boxed warning.

FDA Approves Hemophilia B Second Gene Therapy.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

Genetics and therapy type determine second cancer risk after childhood treatment, study finds

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts

Recommended Articles For You

Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review 

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis 

Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

2.

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

3.

Hypnotherapy may offer real benefits for cancer patient care

4.

Prostate cancer mortality is significantly reduced when docetaxel is used.

5.

Mezigdomide Combinations Show Promise in Multiple Myeloma

1.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

2.

Understanding Iron Saturation Levels in Your Blood 

3.

Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation 

4.

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown

5.

Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

2.

Navigating the Complexities of Ph Negative ALL - Part IX

3.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

4.

Navigating the Complexities of Ph Negative ALL - Part I

5.

Updates on the First Line Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot